Ann S. LaCasce, MD, shares data from the Alliance for Clinical Trials in Oncology's CALGB-50801 trial, which evaluated a PET-adapted approach to cHL therapy.
Ann S. LaCasce, MD, shares data from the Alliance for Clinical Trials in Oncology's CALGB-50801 trial, which evaluated a PET-adapted approach to cHL therapy.
Connect with us:
CURRENT ISSUE
June 2025
